Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Latest PACER......I don't like that clause

The MMP has already brought in mega money and imo will continue to do so in the future. IMO the German validation of the entire MMP was bigger than most here are getting. The USPTO patents are portions of the entire MMP which has been revalidated in entirety in Germany. IMO as a result we have seen a marked increase in MMP licensing recently that should continue while TPL gets the portional MMP patents through the USPTO.

I believe it is way too premature to be jumping to conclusions about the potency of the MMP going forward.

RG is doing his job and that is to diversify and build a company for the future, using the revenue from the MMP. I don't see where RG is making an effort to downplay the role of the MMP. In fact most of the PR's coming out say just the opposite that PTSC will continue to build on the success of the MMP.

All the best,

Steve

Share
New Message
Please login to post a reply